A Feasibility Study of the Nativis Voyager System in Patients with Recurrent Glioblastoma Multiforme (rGBM). This study is currently recruiting qualified patients.
Abstract presented by Xavier Figueroa, PhD, at Society for Neuro-Oncology 2016 Annual Conference, Scottsdale, AZ on November 19, 2016.
The latest information on publications highlighting Nativis research and advancements.
November 7, 2017
Nativis Research Partners to Present at the Society for Neuro-Oncology Annual Meeting in San Francisco
October 23, 2017
CEO Chris Rivera details Nativis’ successes and future goals
October 17, 2017
Nativis Research Partner to Present at COGNO Conference in Australia
Nativis Voyager® ulRFE™ System for rGBM is an investigational medical device. Limited by Federal (or United States) law to investigational use only.
© Nativis 2015 - 2017